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ABSTRACT  
 Macrophages play an essential role in the early immune response against Toxoplasma and are 
the cell type preferentially infected by the parasite in vivo. Interferon gamma (IFNγ) elicits a variety of 
anti-Toxoplasma activities in macrophages. Using a genome-wide CRISPR screen we identified ~130 
Toxoplasma genes that determine parasite fitness in naїve macrophages and ~466 genes that 
determine fitness in IFNγ-stimulated murine macrophages, seven of which we investigated and 
confirmed. We show that one of these genes encodes dense granule protein GRA45, which contains a 
putative chaperone-like domain, and which we show is critical in preventing other GRA effectors from 
aggregating. Parasites lacking GRA45 mislocalize GRA effectors upon secretion, are more susceptible 
to IFNγ-mediated growth inhibition, and have reduced virulence in mice. Our results provide a resource 
for the community to further explore the function of Toxoplasma genes that determine fitness in IFNγ-
stimulated macrophages.  
 
KEYWORDS: Toxoplasma, interferon gamma, CRISPR screen, effector translocation, dense granule, 
chaperone, macrophage   
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IMPORTANCE  
The intracellular parasite Toxoplasma gondii can cause congenital infections and severe disease in 
immunocompromised patients. The cytokine IFNγ can block parasite replication by upregulating a variety 
of toxoplasmacidal mechanisms in many cells, including macrophages. Toxoplasma preferentially infects 
macrophages. Therefore, the parasite has evolved mechanisms to survive in these cells in the presence 
of IFNγ. Here, we generated pools of Toxoplasma mutants for every gene and determined which 
mutants were specifically depleted in IFNγ-stimulated macrophages, thus identifying 
parasite genes determining fitness in these cells. We show that one of these genes encodes for a dense 
granule protein (GRA45) that plays an important role in preventing other GRA effectors from aggregating. 
Parasites without GRA45 mislocalize GRA effectors upon secretion, have enhanced susceptibility to 
IFNγ-mediated growth inhibition, and are avirulent in mice. Thus, our screen provides a resource to 
the Toxoplasma community to determine the function of Toxoplasma genes that affect its fitness in IFNγ-
stimulated macrophages. 
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INTRODUCTION:  
Toxoplasma gondii is an obligate intracellular parasite that causes disease in immunocompromised 
individuals, such as HIV/AIDS patients, and when contracted congenitally (1). It causes lifelong 
infections by converting from rapidly dividing tachyzoite stages into encysted slow-growing bradyzoites, 
which mainly localize to the brain and muscle tissues. Once established in the host cell, Toxoplasma 
resides in a unique replication niche called the parasitophorous vacuole (PV), which is separated from 
the host cytoplasm by the PV membrane (PVM) and does not fuse with the endolysosomal system (2, 
3).  
The cytokine interferon gamma (IFNγ) is essential for the control of Toxoplasma replication in 
host cells (4). Mice with macrophages that can no longer respond to IFNγ are extremely susceptible to 
Toxoplasma demonstrating the crucial role of this cell type in IFNγ-mediated control of Toxoplasma (5). 
IFNγ-induced upregulation of immunity-related GTPases (IRGs) and guanylate binding proteins (GBPs) 
(6–8) are key mechanisms for controlling Toxoplasma in mice (9–13). IRGs and GBPs can bind and 
subsequently vesiculate the PVM, eventually leading to the death of the parasite (14–17). In addition, 
IFNγ induces the production of nitric oxide (NO) and reactive oxygen species, which lead to parasite 
damage and growth restriction in murine macrophages (18). However, the potency of IFNγ-induced 
toxoplasmacidal activities in murine macrophages is parasite-strain dependent, with the clonal type 2 
and 3 strains being more susceptible to IFNγ-induced growth restriction compared to type 1 strains 
(19). 
Toxoplasma co-opts host cells by secreting ROP and GRA effector proteins, from organelles 
called rhoptries and dense granules, respectively, into the host cell or onto the PVM (reviewed in (20)). 
ROP18 (encoding a secreted kinase) (21, 22) and ROP5 (encoding a member of an expanded family of 
pseudokinases) (23, 24) are highly polymorphic and, together with ROP17 (25) and GRA7 (26, 27), 
account for differences in parasite virulence in mice by cooperatively blocking IRG (14, 28–30) and 
GBP (6, 31) loading on the PVM. Other parasite strain-specific effectors include ROP16 and GRA15, 
which can affect GBP loading on the PVM (32) and macrophage polarization into the classical (M1) or 
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alternative (M2) activation phenotypes (33). The pseudokinase ROP54 also inhibits GBP loading on the 
PVM (34). Additional secreted effectors, such as GRA12, affect Toxoplasma survival in murine 
macrophages without affecting the loading of IRGs/GBPs to the PVM (35). Besides targeting IFNγ-
induced host cell effectors, Toxoplasma can directly inhibit IFNγ signaling. For example, through a GRA 
(TgIST) secreted beyond the PVM (36, 37), Toxoplasma can directly inhibit STAT1 transcriptional 
activity (38–40), an essential component of the IFNγ signaling pathway (41). The secretion of GRAs 
beyond the PVM into the host cell cytosol is dependent on the Toxoplasma proteins MYR1/2/3 (42, 43), 
which might form a PVM-localized translocon. A Golgi-resident aspartyl protease ASP5, which cleaves 
the Toxoplasma export element (TEXEL, RRLxx) motif in some GRAs, is required for exported GRAs to 
reach the host cytosol and also for the correct localization of other GRAs confined to the PV (44–46).  
Many of the above-mentioned Toxoplasma virulence genes were identified using genetic 
crosses between strains that differ in virulence in mice. However, this approach fails to identify 
Toxoplasma genes that determine strain-independent survival in IFNγ-activated macrophages.  
Here we used a genome-wide loss-of-function screen in the type 1 (RH) strain, which is resistant to 
IRG/GBP-mediated killing, to identify ~466 Toxoplasma genes that determine fitness in IFNγ-activated 
murine macrophages and ~130 genes that determine fitness in naїve macrophages. Seven of the top 
hits, including GRA45, were confirmed by generating and testing single gene knockouts in functional 
parasite growth assays in IFNγ-activated murine macrophages. We show that GRA45 plays an 
important role in preventing aggregation of other GRA effectors in the secretory pathway. Δgra45 
parasites have enhanced susceptibility to IFNγ-mediated growth inhibition in murine, rat, and human 
macrophages and significantly reduced virulence in mice. Our results provide a resource to the 
community to investigate the mechanism by which other Toxoplasma genes affect fitness in naїve or 
activated macrophages. 
 
RESULTS: 
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A loss-of-function screen identifies Toxoplasma genes that determine fitness in naïve and IFNγ-
activated murine macrophages. 
We previously identified Toxoplasma genes that determine parasite fitness during infection of human 
foreskin fibroblasts (HFFs) using a genome-wide loss-of-function CRISPR/Cas9 screen (47). However, 
it is likely that this set of fitness-conferring genes varies by host cell type, host species, and in infection 
of IFNγ-activated cells. The challenge in Toxoplasma genome-wide loss-of-function screens is to 
maintain the complexity of the mutant pool during the selection. It was previously reported that 
macrophages require stimulation by IFNγ along with LPS or TNFα to effectively restrict Toxoplasma 
growth (48). Such stimulated macrophages are extremely effective in inhibiting Toxoplasma growth, 
even of virulent strains like the type 1 (RH) strain, which would likely pose a tight bottleneck during the 
selection of the mutant parasite pool. IFNγ stimulation by itself was sufficient for a minor but significant 
inhibition of Toxoplasma growth in C57BL/6J murine bone marrow-derived macrophages (BMDMs) 
(Figure S1A), unlike IFNγ + TNFα stimulation that drastically restricted parasite growth (Figure S1B). 
Thus, we reasoned that a loss-of-function screen in macrophages stimulated with IFNγ alone would 
reduce the random loss of mutants while at the same time allowing us to identify mutants that are 
susceptible to IFNγ-mediated restriction of parasite growth. To identify these mutants, we applied a 
genome-wide CRISPR loss-of-function screen in RH parasites constitutively expressing Cas9 (RH-
Cas9) (47). We initially passed the mutant pool in HFFs to remove mutants with general fitness defects 
(e.g., invasion and replication) (Figure 1A). Parasite mutants coming out of the 4th HFF passage were 
subsequently passed three times on either naïve or IFNγ-stimulated BMDMs (100 ng/mL IFNγ for 24 h) 
(referred to as screen 1 or S1) or were continued to be passed on HFFs (Figure 1A and 1B). sgRNAs 
were amplified from the input library, and from parasite DNA isolated after 4th and 8th passages on HFFs 
and three additional passages on naïve or IFNγ-activated BMDMs and enumerated using Illumina 
sequencing. To assess potential bottlenecks and associated random loss of mutants at different 
passages, we enumerated sgRNAs targeting a set of control genes that are only expressed in sexual 
stages and should, therefore, have no fitness effect (49). The sgRNAs targeting these control genes 
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were significantly enriched (p < 0.0001, chi-square) at later passages, confirming that they do not affect 
parasite fitness. However, we noted that there was still a discernible loss of sgRNAs targeting control 
genes in IFNγ-activated BMDMs (S1 in Figure 1C) indicating that some stochastic loss of library 
complexity occurs at this IFNγ concentration. Because an IFNγ concentration of 1 ng/mL induced ~20% 
inhibition of parasite growth (Figure S1A), we repeated the screen in BMDMs pre-stimulated with 1 
ng/mL IFNγ for 24 h (referred to as screen 2 or S2) (Figure 1B). In addition, to better understand the 
changes in stimulated BMDMs that Toxoplasma needs to adapt to, we performed RNA-sequencing 
(RNA-seq) on C57BL/6J and A/J BMDMs stimulated with IFNγ and/or TNFα for 4 h or 24 h. These 
analyses showed that IFNγ stimulation for 4 and 24 h induced the expression of similar gene sets 
(Figure S1C and Table S1) while TNFα-stimulated macrophages had different gene sets and profiles. 
In an attempt to reduce the IFNγ-induced bottleneck in the screen and to identify parasite genes 
important for fitness in IFNγ-stimulated BMDMs and specific for that stimulation, we performed a 3rd 
screen in BMDMs stimulated with IFNγ or TNFα for 4 h before infection with the pool of mutants coming 
out of the 3rd passage on HFFs (referred to as screen 3 or S3) (Figure 1B). There was no apparent 
bottleneck in the S2 and S3 screens (Figure 1C). 
We defined the “fitness score” of a gene as the average log2-fold change abundance of sgRNAs 
targeting the gene in the condition (naïve or stimulated) relative to the input library. We calculated 
fitness scores at the 3rd/4th (“HFF-P3/P4 fitness”) and 6th/8th (“HFF-P6/P8 fitness”) passages in HFFs, or 
after three passages on naïve (“Naïve BMDM fitness”), IFNγ-stimulated (“IFNγ BMDM fitness”), or 
TNFα-stimulated (“TNFα BMDM fitness”) BMDMs (Table S2). The HFF-P3/P4 fitness scores were 
highly correlated (r = 0.81±0.05, mean±SD, n= 3) with previously determined HFFs fitness scores (47), 
highlighting the reproducibility of these screens and demonstrating that up to the point of infecting the 
BMDMs, the mutant pool was behaving as expected.  
Because the intracellular BMDM and HFF environments are likely quite different, certain 
Toxoplasma genes could be important for fitness in naïve BMDMs and not HFFs. To identify this set of 
genes, we subtracted the HFF-P6/P8 fitness scores from the Naïve BMDM fitness scores and focussed 
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on genes with a ≥ 2-fold fitness difference. We also calculated the negative enrichment of sgRNAs 
between Naïve BMDM 3rd passage (P3) and HFF-P6/P8 by using the Model-based Analysis of 
Genome-wide CRISPR/Cas9 Knockout (MAGeCK) algorithm (50). We identified ~130 parasite genes, 
including 9 top hits (Figure 1D and Table 1), with ≥ 2-fold lower fitness and/or a significant negative 
enrichment of sgRNAs (p < 0.05) in Naïve BMDM P3 vs. HFF-P6/P8 in at least two out of the three 
screens (and ≥ 3 sgRNAs present in HFF-P6/P8) (Table S2). To determine if these Toxoplasma genes 
shared biological annotation we performed gene set enrichment analysis (GSEA) (51). We found 
significant enrichment of Toxoplasma genes involved in folate metabolism (TGGT1_305800, 
TGGT1_253780, TGGT1_231920, TGGT1_212740, TGGT1_266366 (BT1 folate transporter (52)), 
purine metabolism (TGGT1_224840, TGGT1_257080, TGGT1_250880 (adenosine kinase), 
TGGT1_243580, TGGT1_282190), parasite membrane-localized transporters (TGGT1_226110, 
TGGT1_315560 (TgABCG77), TgApiAT3-1, TgApiAT6-2, TgApiAT6-3) and genes encoding for 
proteins with a Surface Antigen 1 Related Sequence (SRS) domain, which are glycosylphosphatidyl 
(GPI)-linked developmentally-regulated surface proteins that are involved in attachment/invasion (53) 
(Table S3). Overall these data suggest that the nutrient availability to Toxoplasma in naïve BMDMs and 
HFFs is variable and that Toxoplasma uses different SRS proteins to attach/invade BMDMs vs. HFFs. 
Next, we subtracted the Naïve BMDM fitness scores from the IFNγ BMDM fitness scores to 
identify Toxoplasma genes that specifically determine fitness in IFNγ-stimulated BMDMs. In addition, 
we identified genes with a negative enrichment of sgRNAs between naïve and IFNγ-stimulated BMDMs 
at P3 (Table S2). We identified ~466 parasite genes with ≥ 2-fold lower fitness and/or a significant 
negative enrichment of sgRNAs (p < 0.05) in IFNγ-stimulated, relative to naïve BMDMs P3 in at least 
two out of the three screens (and ≥ 3 sgRNAs present in naïve BMDMa) (Table S2). ROP18 and 
GRA12, which are known to determine RH resistance to IFNγ, had a 2.2 fold and 5.2 fold lower fitness 
in IFNγ-stimulated BMDMs, respectively. It should be noted that ROP5 was not in our list of hits 
because sgRNAs against ROP5 were not in our library because the sgRNA design algorithm excluded 
ROP5-targeting sgRNAs because no uniquely targeting sgRNAs could be designed as ROP5 is a multi-
All rights reserved. No reuse allowed without permission. 
was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint (which. http://dx.doi.org/10.1101/867705doi: bioRxiv preprint first posted online Dec. 6, 2019; 
copy gene. Genes encoding for proteins involved in DNA repair (TGGT1_206400, TGGT1_220120, 
TGGT1_251670, TGGT1_272900, TGGT1_295340, TGGT1_307650, TGGT1_320110), nucleic acid 
binding proteins - especially proteins containing RNA-binding/recognition motifs - were significantly 
enriched (Table S3). In addition, we performed pathway analysis on the RNAseq data of activated 
macrophages to identify pathways that are uniquely regulated by IFNγ. The cholesterol biosynthesis 
pathway (Figure S1D and S1E) and many other metabolic pathways were significantly downregulated 
in IFNγ-stimulated but not in TNFα-stimulated BMDMs (Table S1). Indeed, most of the Toxoplasma 
genes that determine fitness in IFNγ-stimulated BMDM and were involved in lipid biosynthesis/transport 
had fitness defects specifically in IFNγ-stimulated cells (Table S1), suggesting that they are required for 
responding to changes in cholesterol levels in IFNγ-stimulated BMDMs. For example, genes involved in 
lipid biosynthesis or transport were enriched in IFNγ-activated BMDMs: three GNS1/SUR4 family 
members involved in long-chain fatty acid elongation and sphingolipid/ceramide biosynthesis 
(TGGT1_253880, TGGT1_205350, TGGT1_242380), TGGT1_229140 (enoyl-CoA hydratase like-beta-
oxidation), GRA38 (an orthologue of GRA39 of which the knockout has been shown to accumulate lipid 
(54)), ATP-binding cassette (ABC) transporters ABCG87 and ABCG96, which have been shown to 
mediate cholesterol transport (55), and TGGT1_266640 (Acetyl-coenzyme A synthetase 2). A 
GNS1/SUR4 family member, TGGT1_205350, was recently identified as a gene important during in 
vivo infection of the peritoneum (49). IFNγ stimulation significantly downregulated the cholesterol 
biosynthesis pathway in BMDMs as has been shown by others (56). It is, therefore, possible that 
Toxoplasma needs to modify its acquisition/export or own production of lipids in IFNγ-stimulated 
BMDMs. The top 16 candidate genes that differed in fitness in IFNγ-stimulated vs. naïve BMDM at P3 
and were specifically depleted in IFNγ-activated BMDMs (Figure 1E) are presented in Table 1. This 
table contains the ROM1 and SUB2 proteases, important for microneme proteins (MICs) processing 
and rhoptry protein maturation, respectively (57, 58), possibly indicating the role of specific MICs and 
ROPs in the invasion of and survival in IFNγ-activated macrophages; TgCPL, important for the 
digestion of host cytosolic proteins in the parasite lysosomal-like organelle called the VAC (59); 
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TGGT1_221170, a putative CAAX Metallo endopeptidase involved in the cleavage of isoprenylated 
proteins; three putative DNA repair proteins TGGT1_269620, TGGT1_209500, and TGGT1_295340; 
three proteins involved in intracellular trafficking, TGGT1_232670 (putative Cytohesin-3), 
TGGT1_231210 (putative dynamin-like protein), and TGGT1_240980 (putative cytoplasmic dynein); 
and four dense granule proteins GRA22, GRA45, GRA46, and a putative GRA, TGGT1_263560.  
Taken together, we have identified multiple Toxoplasma genes that appear to confer fitness 
specifically in naïve or IFNγ-stimulated BMDM, likely because they are needed to adapt to differences 
in levels of nutrients Toxoplasma acquires from its host cells and to the multiple other pathways that are 
modulated by IFNγ.  
 
Single gene knockouts from hits identified by CRISPR screens have fitness defects in IFNγ-
activated BMDM 
To confirm some of the parasite genes that determine fitness in IFNγ-activated BMDMs, we generated 
individual knockouts of four genes (TGGT1_269620, GRA45, TGGT1_232670, and TGGT1_263560) in 
luciferase-expressing RH parasites (Figure S2A to S2F). All knockouts had reduced growth compared 
to wild-type parasites in IFNγ-activated BMDMs as determined by luciferase assays at 24 h p.i. (Figure 
2A to 2D). We previously determined the contribution to the in vivo fitness of 217 Toxoplasma genes 
(49). Of the 24 genes that determined in vivo fitness, two genes (TGGT1_205350 and GRA22) were 
present in the top hits for fitness in IFNγ-activated BMDMs (Table 1). We previously confirmed that 
Δgra22 and ΔTGGT1_269950 parasites were outcompeted by wild-type in the peritoneum. IFNγ-
stimulated BMDMs significantly inhibited Δgra22 and ΔTGGT1_269950 parasite growth relative to wild-
type parasites (Figure 2E, 2F). These results indicate that the in vivo fitness defect of these two genes 
is likely due to their importance in determining parasite fitness in IFNγ-stimulated peritoneal 
macrophages. Most of the knockouts had no, or a minor, fitness defect in mouse embryonic fibroblasts 
(MEFs) or naïve murine BMDMs (Figure S3A to S3G). ΔTGGT1_263560 and Δgra22 parasites formed 
larger plaques compared to wild-type parasites in MEFs, although this was only significant for 
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ΔTGGT1_263560 (Figure S3G). Although the ΔTGGT1_263560 plaques were larger, they appeared 
quite different compared to wild-type plaques; the lysis area contained very few parasites and host 
cells, possibly due to an early egress phenotype (Figure S3H). To test the impact of candidate gene 
knockout in a non-luciferase expressing type 1 (RH) strain, we performed a growth competition assay, 
in which growth differences between wild-type and knockouts accumulate over three passages in both 
naïve and IFNγ-activated BMDMs. As a control, Δgra22 parasites were outcompeted by wild-type 
parasites only in the IFNγ-activated but not naïve BMDMs (Figure 2G). Similar to Δgra22 parasites, 
parasites lacking ROM1 (Figure S2G) were outcompeted by wild-type parasites in IFNγ-activated 
BMDMs (Figure 2H). Thus, the parasite genes identified by our genome-wide loss-of-function screen 
indeed determine parasite fitness in IFNγ-activated BMDM. 
 
GRA45, a top hit from the screen, is important for parasite fitness in IFNγ-stimulated 
macrophages of other species. 
Of the seven genes we confirmed to have a fitness defect in IFNγ-activated BMDM, four genes 
(GRA22, GRA45, TGGT1_263560, and TGGT1_269950) encode for known or putative GRAs (45, 54, 
60). However, of these four GRAs, only GRA22 was previously characterized and shown to contribute 
to parasite natural egress (60), while GRA45 was recently discovered as an ASP5 substrate with 
unknown function (45). Macrophages from different species have different mechanisms to control 
Toxoplasma growth (8) and therefore knowing if these genes are important for conferring resistance to 
IFNγ in other species could help us narrow down the possible mechanism by which they do so. To test 
if these two GRAs are also important for parasite fitness in IFNγ-stimulated macrophages of other 
species, primary rat BMDMs and human THP-1 macrophages were stimulated with IFNγ or left 
unstimulated followed by infection with wild-type, Δgra22 or Δgra45 parasites (Figure 3). Δgra45 
parasites, but not Δgra22 parasites, were significantly more susceptible to IFNγ-mediated growth 
inhibition compared to wild-type parasites in both rat and human macrophages (Figure 3) indicating 
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GRA45 plays an important function in the resistance of Toxoplasma to IFNγ in multiple species. We 
therefore decided to focus on determining the function of GRA45. 
 
GRA45 has structural homology to protein chaperones  
GRA45 was recently shown to interact with GRA44 (TGGT1_221870) and With-No-Gly-loop (WNG)2 
kinase (TGGT1_240090), which also localize to dense granules. GRA45, GRA44 and WNG2 are 
relatively conserved and orthologues are present in coccidian species belonging to the Sarcocystidae 
(Neospora caninum, Hammondia hammondi, Cystoisospora suis, Sarcocystis neurona) and Eimeriidae 
(Eimeria spp. and Cyclospora cayetanensis). This is a rather unique phylogenetic profile as most GRAs 
are only conserved within the Toxoplasmatinae suggesting that these GRAs have a conserved function 
in these different parasite species. GRA45 is highly expressed in tachyzoite and bradyzoite stages and 
has moderate expression levels in sexual stages (ToxoDB.org). A paralogue of GRA45 exists in 
Toxoplasma (TGGT1_295390), which is exclusively expressed in sexual stages. Interestingly, GRA44 
is duplicated and one copy (TGGT1_221860) is also exclusively expressed in sexual stages. Searches 
for primary sequence homology or known protein domains failed to provide any suggestions for putative 
GRA45 functions. However, homology searches based on secondary structure prediction indicated that 
the N-terminal region of GRA45 (from amino acids 72 to 225) has structural homology to small heat 
shock proteins (sHSPs) (Figure S4A), which are ATP-independent chaperones that prevent protein 
aggregation. The conserved [I/V/L]x[I/V/L] signature present at the C-terminus of most sHSP was 
conserved in GRA45 (RIDVH from amino acid 204 to 208) and its orthologues. The most significant 
structural homology was to Aggregation Suppressing Protein A (AspA) from Salmonella typhimurium 
(61) and HSP17.9 from Xylella fastidiosa (62). The GRA45 C-terminal region (amino acids 260-335) 
had structural homology to DUF1812 domains (63) and Mfa2 (64), which share a transthyretin-like fold 
(Figure S4A). Transthyretin family members are known to transport lipids such as retinol and thyroxine 
(65). In addition, the top 10 models with GRA45 structural homology, as predicted by I-TASSER (66), 
are predicted to bind hydrophobic substrates as they have acyltransferase domains. Overall these data 
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indicate that a potential function of GRA45 is binding of hydrophobic substrates and preventing their 
aggregation. GRA45 possesses an N-terminal TEXEL (RRL) motif that is cleaved by ASP5 (45). 
Consistent with published results that GRA45 remains in the PV lumen after secretion (45), we 
observed that almost all GRA45 co-localized with PV-resident GRA1 and GRA2 in the PV lumen but 
only partially with PVM-associated GRA5 and GRA7, even though these GRAs all localize to dense 
granules in extracellular parasites (Figure S4B). Thus, GRA45 is unlikely to be a Toxoplasma effector 
that directly modulates or inhibits IFNγ-induced host effector mechanisms. 
 
Deletion of GRA45 leads to aggregation of dense granule proteins inside the parasite. 
Based on its structural homology to sHSPs, we hypothesized that instead of directly neutralizing IFNγ-
mediated inhibition GRA45 might perform a chaperone-like function by binding to the hydrophobic 
domain present in many GRA effectors, thereby preventing their aggregation. GRAs with a 
transmembrane domain have peculiar trafficking and do not traffic to the parasite plasma membrane 
but instead traffic to the dense granules where they exist in a soluble state (67). What prevents their 
transmembrane domain from inserting into the ER membrane or the dense granule membrane is 
unknown but has been hypothesized to be mediated by a dense-granule-localized chaperone (67, 68). 
After exocytosis of the dense granules, these transmembrane-containing GRAs somehow integrate as 
type I transmembrane proteins into the PVM and/or intravacuolar network (IVN). To test the hypothesis 
that GRA45 plays a role in preventing the aggregation of GRAs, we examined the solubility of 
hydrophobic GRAs, such as GRA2, which has two amphipathic helices that mediate its membrane 
association post-secretion (69), and GRA7, which contains a transmembrane domain but localizes to 
the dense granule core and does not integrate into the dense granule membrane (70, 71). In wild-type 
parasite lysates generated by freeze/thawing, GRA2 and GRA7 were mainly present in the pellet 
fraction and ran according to their corresponding molecular weight (MW) in denaturing conditions 
(Figure 4A, left panels). In addition to their corresponding MW, in Δgra45 parasites, GRA2 and GRA7 
appeared at a much higher MW as bands that were not completely separated during the gel migration 
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consistent with protein aggregation. These high MW bands of GRA2 and GRA7 were barely observed 
in wild-type or in Δgra45 parasites complemented with an HA-tagged version of GRA45 
(Δgra45+GRA45HA, Figure S2C) (Figure 4A, left panels). As a control, we used the parasite plasma 
membrane protein SAG1, which traffics to the parasite surface independent of dense granules and 
should therefore not be affected by GRA45. No higher MW bands of SAG1 were observed in any of the 
parasite strains (Figure 4A, left panels) indicating that the aggregation of GRA2 or GRA7 was not due 
to excess sample loading. After treatment with non-ionic detergents (NP-40 or Triton X-100), which 
solubilize membrane proteins by associating with their hydrophobic surface, non-aggregated GRA2 and 
GRA7 running at the expected MW were completely solubilized and released into the supernatant 
fraction in all the strains. However, in the Δgra45 parasites, the high MW bands of GRA2 and GRA7 
were still mostly present in the pellet fraction (Figure 4A, middle and right panels). The presence and 
the persistence of high MW bands corresponding to GRA2 and GRA7 in Δgra45 parasites are 
consistent with their aggregation, possibly via noncovalent hydrophobic interactions inside the dense 
granules.  
To determine if the solubility of GRAs was also affected after exocytosis into the PV we 
performed cell fractionation of intracellular parasites. Intact parasites, mechanically released from host 
cells and pelleted and resuspended in lysis buffer containing DTT, are referred to as the low-speed 
pellet (LSP). The supernatant (LSS), which contains PVM and host cell material, was fractionated with 
high-speed centrifugation to isolate the supernatant (HSS) and pellet (HSP) fractions. The HSP-
containing PVM and other membrane fractions (for example, the IVN) was subjected to detergent 
treatment to extract the membrane-associated GRAs or left untreated. We examined different GRAs 
based on their final destinations in the PV and their membrane association properties: GRA1, localizes 
to the PV lumen as a soluble protein (72, 73); GRA2, is an IVN-associated protein (72); GRA5, is a 
PVM-integrated protein that faces to the host cytosol (74, 75); and GRA7, associates with IVN and 
PVM (70, 71), and strands extending from PVM into the host cytosol (76). In all strains, GRA1 is mainly 
found in the soluble fraction and also in the LSP that contains intact parasites. However, in Δgra45 
All rights reserved. No reuse allowed without permission. 
was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint (which. http://dx.doi.org/10.1101/867705doi: bioRxiv preprint first posted online Dec. 6, 2019; 
parasites the LSP of intact parasites and the insoluble HSP fraction without detergent treatment 
contained high MW GRA1, while it remained in both Triton X-100-treated HSP and HSS (Figure 4B). 
The insoluble GRA2 was extracted from the HSP after Triton X-100 treatment in all parasite strains, but 
the high MW of GRA2 was resistant to extraction by Triton X-100 in Δgra45 parasites (Figure 4B). 
Although we did not observe GRA5 high MW bands, GRA5 in the insoluble fraction was less extracted 
from the HSP after Triton X-100 treatment in Δgra45 parasites compared to wild-type and 
Δgra45+GRA45HA parasites (Figure 4B). Intracellularly, GRA7 is present as a non-phosphorylated 
protein running at 26 kDa and a phosphorylated protein running at 32 kDa (Figure 4B), which is only 
present in infected host cells in the PVM where it faces to the host cytosol (77). GRA7 was also well 
extracted from the HSP after Triton X-100 treatment in all the parasite strains, but in Δgra45 parasites 
the phosphorylated form of GRA7 was less abundant compared to wild-type and Δgra45+GRA45HA 
parasites (Figure 4B) indicating GRA7 was not properly localized to the PVM in Δgra45 parasites. 
Taken together, these results indicate that without GRA45 the GRAs inside the dense granules 
aggregate, which subsequently appears to lead to their mislocalization after exocytosis into the PV. 
 
Deletion of GRA45 leads to the mislocalization of GRAs upon exocytosis of dense granules. 
Because we observed aggregation of GRA proteins in the parasite we wanted to determine if the 
localization of GRAs after exocytosis of the dense granules was affected. We initially focused on 
GRA23, as it is almost exclusively localized to the PVM (78, 79), where it plays a role as a molecular 
sieve (80) allowing passive size-dependent import of host-derived small molecules. However, in Δgra45 
parasites, a large fraction of GRA23 was mislocalized to the PV lumen whereas the localization 
remained normal in the parasites lacking MYR1 (Δmyr1) (Figure S2D), which is served as a control as 
it was shown that Δmyr1 parasites have normal function of PVM-localized GRAs (42) (Figure 4D). 
Given that GRA7 and GRA23, which are normally localized to the PVM, appeared to be mislocalized in 
Δgra45 parasites, we hypothesized that components of the translocon involved in GRA translocation 
across the PVM could also be mislocalized. To test this hypothesis, we generated Δgra45 parasites in a 
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strain where MYR1 was endogenously tagged with 3xHA epitopes (Figure S2C and S2I). Although we 
did not observe any high MW bands corresponding to MYR1 in Δgra45 parasites (data not shown), 
MYR1 was more resistant to detergent extraction and less abundant in the soluble fraction of Δgra45 
parasites compared to wild-type parasites (Figure 4E) indicating GRA45 is also involved in maintaining 
MYR1 soluble. However, it is unclear what happens to the N-terminus of MYR1 in Δgra45 parasites, as 
MYR1 is cleaved by ASP5 into an N-terminal and C-terminal polypeptide (42, 81) and only the C-
terminal MYR1 polypeptide was observed for this experiment. Furthermore, MYR2 and MYR3 are also 
required for GRA effector translocation into the host cell (43). We therefore indirectly assessed if a 
translocon-mediated phenotype was affected in Δgra45 parasites by determining GRA16 and GRA24 
export beyond the PVM. Indeed, GRA16 and GRA24 were no longer exported beyond the PVM in 
Δgra45 parasites, as observed by their absence from host nuclei (Figure 4F and 4H), which was 
similar to the Δmyr1 phenotype (Figure 4G and 4I). Overall, these data indicate that GRA45 either 
affects the correct assembly of the translocon into the PVM or the correct trafficking of GRA effectors to 
the translocon.  
 
GRA45 is important for parasite virulence. 
Since the data suggest that GRA45 affects the correct localization of GRA proteins to the PVM and 
export beyond the PVM and without GRA45 many GRAs aggregate, it is conceivable that the fitness 
defect of Δgra45 parasites in IFNγ-stimulated BMDMs was due to the defect of GRA effector export 
beyond the PVM. However, the translocon components MYR1/2/3 did not emerge as hits in our loss-of-
function screen in IFNγ-stimulated BMDMs (Figure 5A). GRA45 has a significantly lower IFNγ BMDM 
vs. Naïve BMDM fitness score compared to MYR1/2/3 across the three screens (Figure 5B). To 
confirm the results from the screen we compared side-by-side the susceptibility of Δgra45 and Δmyr1 
parasites to IFNγ-mediated growth inhibition. In murine BMDMs pre-stimulated with increasing 
concentrations of IFNγ, we observed that Δgra45, but not Δmyr1, parasites were more susceptible than 
either wild-type or Δgra45+GRA45HA parasites to IFNγ-mediated growth inhibition (Figure 5C). To 
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determine if these in vitro differences also translated to differences in virulence in mice, we 
intraperitoneally (i.p.) infected mice with 100 tachyzoites of wild-type, Δgra45, Δmyr1, 
Δgra45+GRA45HA parasites and monitored parasite virulence. Consistent with the in vitro data, 
Δgra45, but not Δmyr1, parasites were significantly less virulent compared to wild-type or GRA45 
complemented parasites (Figure 5D). These data indicate that the effect of GRA45 on parasite 
virulence cannot be solely explained by the defect in GRA export beyond the vacuole but is likely due to 
the combined defect in GRA export beyond the vacuole and the defect in correct GRA localization in 
the PV. 
 
DISCUSSION: 
Evading the host immune response and reaching immune-privileged organs is essential for 
Toxoplasma to establish a lifelong chronic infection. The complete set of Toxoplasma genes involved in 
these processes is currently unknown. We recently published an in vivo loss-of-function screen using a 
focused sgRNA library enriched in GRA-targeting sgRNAs to determine the in vivo fitness contribution 
of Toxoplasma genes in the mouse peritoneum and in distant organs (49). It is likely that a significant 
fraction of the Toxoplasma genes that determined fitness at the site of infection were important for 
resisting the toxoplasmacidal mechanisms of IFNγ-activated cells or determined parasite growth and 
survival inside macrophages, the cell type preferentially infected by Toxoplasma.  
Here, we identified the Toxoplasma genes that determine fitness in naïve or IFNγ-activated 
BMDMs. Many of these parasite genes appear to be involved in nutrient acquisition, likely because 
IFNγ modulates cholesterol biosynthesis and many other nutrient pathways in macrophages. 
TgApiAT3-1, TgApiAT6-2 or TgApiAT6-3, which determined fitness in naïve BMDMs, were previously 
shown to have no fitness defect in HFFs (82) but their phenotype in BMDMs was not investigated. 
TgApiAT6-2 was reported to determine resistance to sinefungin (83), which is an S-adenosylmethionine 
(SAM) analog, likely by mediating the transport of sinefungin into the parasite. SAM is a methyl donor 
important for many biological processes. Although the TgApiAT6-2 knockout was reported to have no 
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phenotype in vitro or in vivo, this was only assessed in the hyper-virulent atypical VAND strain (83). 
TgABCG77, which had a lower fitness score in naïve BMDMs vs. HFFs, is upregulated by excess 
cholesterol or LDL and is involved in cholesterol export by Toxoplasma (55) suggesting that 
Toxoplasma has a greater need to export cholesterol in BMDMs. It is well known that Toxoplasma is a 
glutton for host-derived lipids and takes up more than it can safely store in lipid droplets. Because 
excess lipids, especially free cholesterol, can be toxic, our data suggest that in BMDMs, Toxoplasma 
might import more cholesterol and the inability to export excess cholesterol in these cells is likely toxic 
to the parasite (84). Toxoplasma genes involved in DNA repair were more important for fitness in IFNγ-
activated vs. naïve BMDM. Possibly the generation of oxygen and/or NO radicals generates DNA 
damage that Toxoplasma needs to repair. A previous mutagenesis study (85) identified several 
Toxoplasma mutants that had defects in growth in stimulated murine macrophages. This study 
identified TgCAP1 (TGGT1_210810) to be important for resistance against NO in macrophages (85). In 
our study, TgCAP1 had an ~2-fold larger fitness defect in IFNγ-activated vs. naïve BMDMs indicating 
that Toxoplasma genes important for resisting host-generated radicals are important for its fitness. 
Parasite genes that are important for fitness in IFNγ-stimulated BMDMs were enriched for RNA-binding 
proteins. Conditions of stress that lead to inhibition of global protein synthesis (e.g., nutrient starvation 
or oxidative stress) will cause polysomes to disassemble, ribosomes to release their transcripts and the 
accumulation of mRNA with pre-initiation complexes in stress granules (86). It was previously shown 
that extracellular Toxoplasma have abundant RNA granules, which dissolve when the parasite invades 
a host cell. The parasites with more abundant “stress granules or RNA granules” have enhanced 
growth, increased invasion, and decreased apoptosis when extracellularly (87). It is possible that the 
RNA-binding proteins identified by our screen might play a role in stress granules and adaptation to 
stress encountered in IFNγ-stimulated BMDM.  
Our screen likely missed parasite genes that determine fitness in HFFs but that might have an 
even larger effect on fitness in naïve or IFNγ-stimulated BMDMs (for example ASP5, (44)) because we 
started our screen after three to four passages in HFFs. At that point, mutants with a fitness defect in 
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HFFs would have already been depleted and therefore, might not have met the threshold to be included 
in our analysis (≥ 3 different sgRNAs targeting a specific gene present after the last passage in HFFs). 
The large number of host cells needed to maintain the complexity of the genome-wide library of parasite 
mutants made it impractical to directly perform the screen in BMDMs. However, future focused screens 
could directly start in BMDMs and thereby avoid this limitation. Because IFNγ regulates multiple pathways 
in murine BMDMs, it is difficult to predict the exact function of each Toxoplasma gene that confers fitness 
in IFNγ-stimulated BMDMs. Comparing the macrophage pathways differentially regulated by IFNγ vs. 
TNFα can start to classify parasite genes that differ in determining fitness in these two conditions. For 
example, the cholesterol biosynthesis pathway was significantly downregulated in IFNγ- but only 
marginally downregulated in TNFα-stimulated BMDMs, consistent with previous observations (56), and 
therefore parasite genes important for adaptation to host cholesterol levels should have fitness defects 
in IFNγ- but not in TNFα-stimulated BMDMs. However, future secondary screens where only one specific 
pathway regulated by IFNγ is investigated, for example, the presence of oxygen radicals or the 
downregulation of the cholesterol pathway, are needed to more definitively classify our hits in different 
categories.  
One of the most significant parasite genes conferring fitness in IFNγ-stimulated BMDMs was 
GRA45. Deletion of GRA45 had pleiotropic effects likely because without GRA45, many GRAs 
aggregated within the parasite’s secretory dense granule organelles. This led to the mislocalization of 
GRA effectors upon dense granule exocytosis and is also the most likely explanation for its importance 
in multiple species. GRA16 and GRA24, which are normally secreted beyond the PVM, are no longer 
secreted in Δgra45 parasites. It is unlikely that the fitness defect of Δgra45 parasites was due to the 
defect in GRA effector export beyond the PVM as Δmyr1 parasites were not significantly more susceptible 
to IFNγ than wild-type parasites. Although it was previously shown that the secreted GRA effector TgIST 
is important for resistance against IFNγ, deletion of TgIST had no effect on parasite susceptibility to IFNγ-
pre-stimulated cells (36, 37), which is consistent with our results. It is therefore likely that the susceptibility 
of Δgra45 parasites is due to the combined effect of missing multiple secreted effectors and 
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mislocalization of PVM proteins. For example, the PVM-localized GRA23 and GRA17 form the nutrient 
pore in the PVM and GRA23 was mislocalized in Δgra45 parasites. GRA23 also had a ~2-fold stronger 
fitness defect in naïve BMDMs vs. HFFs suggesting that Toxoplasma might be more reliant on nutrient 
acquisition via PVM nutrient pores in BMDMs. A GRA45 orthologue is exclusively expressed in cat 
intestinal stages, we speculate that it could be involved in preventing protein aggregation inside wall-
forming bodies that are involved in the formation of the oocyst wall. 
 It was recently shown that phosphorylation of GRAs by WNG1, a closely related family member 
of WNG2, after exocytosis from the dense granules is important for the correct localization of 
transmembrane-domain-containing GRAs (68). We have shown that GRA42 and GRA43 also play a 
role in the correct trafficking of PVM-localized GRAs and that in Δgra42 or Δgra43 parasites GRA23 
and GRA35 are mislocalized (79). Exactly how WNG1, GRA42, GRA43 and GRA45 function in the 
GRA trafficking pathway is currently unknown. Gram negative bacteria face a similar problem as 
Toxoplasma and also need to transport proteins across several membranes to reach the outer 
membrane. These bacteria use different periplasmic chaperones and different transport systems to 
traffick lipoproteins (the Lol system), β-barrel proteins (the Bam system), or Lipopolysaccharides (the 
Lpt system) (88, 89). It is likely that Toxoplasma also has different PV-lumen-localized chaperones and 
different transport systems to mediate the trafficking of different classes of membrane proteins (e.g., 
integral vs. peripheral vs. alpha helical). Possibly genes encoding for some of these were hits in our 
screen. Future more focussed screens and testing additional knockouts of hits from our screen will 
allow the identification of Toxoplasma genes that mediate the correct trafficking of GRAs to their final 
destination.  
 
MATERIALS AND METHODS 
Animals 
BMDMs were obtained from 6 to 8 weeks old male/female C57BL/6J mice (Stock No: 000664) and A/J 
mice (Stock No: 000646) purchased from The Jackson Laboratory. CD-1 female mice were purchased 
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from Charles River Laboratories (Strain Code: 022) and used for in vivo infection experiments. 6 to 8 
weeks old female/male Brown Norway rats (Strain Code: 091) were purchased from Charles River 
Laboratories.  
 
Cell Lines  
HFFs were cultured in DMEM, 10% fetal bovine serum (FBS), 2 mM L-glutamine, 100 U/mL 
penicillin/streptomycin, 10 mg/mL gentamicin. MEFs were cultured in DMEM, 10% fetal bovine serum 
(FBS), 2mM L-glutamine, 10mM HEPES, 1x non-essential amino acids, 1 mM sodium pyruvate, 100 
U/mL penicillin/streptomycin, 10 mg/mL gentamicin. The THP-1 cells were cultured in RPMI-1640, 10% 
fetal bovine serum (FBS), 2 mM L-glutamine, 100 U/mL penicillin/streptomycin, 10 mg/mL gentamicin. 
For differentiation, THP-1 cells were stimulated with 100 nM phorbol 12-myristate 13-acetate (PMA) for 
3 days and then rested for 1 day by replacing the differentiation medium with complete medium without 
PMA before performing experiments. Murine BMDMs were isolated from 5 to 8 weeks old female 
C57BL/6J mice or A/J mice (The Jackson Laboratory) as previously described (90), and obtained by 
culturing murine bone marrow cells in DMEM, 10% fetal bovine serum (FBS), 2 mM L-glutamine, 10 
mM HEPES, 1x non-essential amino acids, 1 mM sodium pyruvate, 100 U/mL penicillin/streptomycin, 
10 mg/mL gentamicin and 20% L929 conditioned medium for 5 to 7 days. Rat BMDMs were isolated 
from 6 to 8 weeks old female Brown Norway rats (Charles River Laboratories) as previously described 
(49), and obtained by culturing rat bone marrow cells in DMEM, 20% fetal bovine serum (FBS), 2 mM 
L-glutamine, 10 mM HEPES, 1x non-essential amino acids, 1 mM sodium pyruvate, 100 U/mL 
penicillin/streptomycin, 10 mg/mL gentamicin and 30% L929 conditioned medium for 5 to 7 days.  
 
Plasmid construction 
The pU6-Universal plasmid (91) was used for generating the plasmid containing sgRNAs targeting the 
candidate genes. Briefly, the constructs were generated by annealing oligos containing the sequence of 
sgRNAs (Table S4) which were cloned into the BsaI-digested pU6-Universal plasmid. The 
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pUPRT::DHFR-D (Addgene, Cat#58528) plasmid backbone with PCR-amplification to remove the DHFR 
cassette was used to generate the construct for making the GRA45 complementation. The promoter 
region (~1,500 bp upstream to the start codon) and the coding sequence of GRA45 were amplified and 
flanked with the HA epitope sequence before the stop codon. The 3’-UTR region (~500 bp) was also 
amplified and assembled with the other two fragments using Gibson Assembly. To construct the plasmid 
for generating the GRA45 endogenously HA-tagged strain, ~1,300 bp upstream of the stop codon of 
GRA45 was amplified by PCR and inserted into pLIC-3xHA-DHFR by ligation-independent cloning (92). 
All PCR primers are listed in Table 5S. 
 
Generation of parasite strains 
Toxoplasma gondii parasites were routinely passaged in vitro on monolayers of HFFs at 37°C in 5% 
CO2 as previously described (Rosowski et al., 2011). Individual knockout of candidate genes was 
performed using CRISPR-Cas9 (91, 93). To generate the knockout strains for candidate fitness-
conferring genes in IFNγ-activated BMDMs, plasmids containing sgRNAs were co-transfected with NotI 
(New England Biolabs)-linearized pTKO, which contains the HXGPRT selection cassette and GFP (94), 
into RH-Luc+/Δhxgprt parasites at a ratio 5:1 of sgRNA to linearized pTKO plasmid. 24 h post-
transfection, populations were selected with mycophenolic acid (50 μg/mL) and xanthine (50 μg/mL) 
and cloned by limiting dilution (Figure S2A). Individual knockout clones were confirmed by PCR 
(Figure S2D to S2F). In addition to generating knockouts in the RH-Luc+/Δhxgprt strain, the RH-
Cas9/Δhxgprt strain (95) was used to generate Δgra22 and Δrom1 parasites (Figure S2G and S2H) 
using the same strategy. To generate the GRA45 complemented strain (Figure S2B), the RH-
Luc+/Δgra45 parasites were co-transfected with plasmids containing sgRNAs specifically targeting the 
UPRT locus and SalI (New England Biolabs)-linearized pUPRT::GRA45HA plasmid at a ratio 1:5 of 
sgRNAs to linearized plasmid. After the first 2 complete lysis cycles, populations were selected with 10 
μM of 5-fluoro-2-deoxyuridine (FUDR) for another 2 complete lysis cycles. Individual clones were 
isolated by limiting dilution and the presence of GRA45HA was determined by immunofluorescence 
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assay (IFA) and by PCR to confirm the integration into the UPRT locus (Figure S2D). The GRA45 
knockout in RHΔku80::MYR1-3xHA strain (kindly provided by Dr. John Boothroyd) was generated by 
co-transfecting plasmids containing sgRNAs targeting the GRA45 locus along with an amplicon 
harboring GRA45 homology regions (60 bp) surrounding a pyrimethamine-resistant (DHFR*) cassette 
(Figure S2C). Individual knockout clones were grown in medium supplemented with 3 μM 
pyrimethamine followed by limiting dilution and subsequent screening by PCR for correct integration of 
DHFR* into the GRA45 locus (Figure S2I). GRA45 endogenously HA-tagged parasites were made in 
the RHΔku80Δhxgprt strain (92) by transfection with the plasmid pLIC-GRA45-3xHA-DHFR. 
Transfected parasite populations were selected with 3μM pyrimethamine and cloned by limiting dilution. 
The presence of the GRA45-3xHA was determined by immunofluorescence assays. 
 
Toxoplasma gondii CRISPR-Cas9 mediated genome-wide loss-of-function screens 
At least 5x108 parasites were transfected with a mixture of pU6-DHFR plasmids (100 μg for each 1x108 
parasites) containing 10 different sgRNAs against every Toxoplasma gene. A monolayer of human 
foreskin fibroblasts (HFFs) was subsequently infected with the parasites (MOI=0.5) and grown for 24 h 
in DMEM containing 1% FBS, 2 mM L-Glutamine, 1% penicillin/streptomycin, and 40 µM 
Chloramphenicol (CAT). Subsequently, the medium was removed and replaced with DMEM containing 
10% FBS, 2 mM L-Glutamine, 10 mM HEPES, 1x Non-Essential Amino Acids, 1 mM Sodium Pyruvate, 
100 U/mL Pen/Strep, 10 µg/mL gentamicin, 40 µM CAT Chloramphenicol, 1 µM Pyrimethamine, and 10 
µg/mL DNase I for 3 or 4 passages. To perform the screen in murine macrophages, BMDMs isolated 
from C57BL/6J mice were stimulated with: 100 ng/mL IFNγ for 24 h for screen 1 (S1), 1 ng/mL IFNγ for 
24 h for screen 2 (S2), or 100 ng/mL IFNγ for 4 h or 100 ng/mL TNFα for 4 h for screen 3 (S3). Both 
naïve BMDMs and stimulated BMDMs were infected with the mutant pool derived from the 3rd or 4th 
passage in HFFs at an MOI of 0.5. After 48 h infection (the time the mutant parasites nearly egressed 
from the host cells), the parasites were harvested, counted and used to infect macrophages that had 
undergone the same stimulation until the 3rd passage (Figure 1B). For each passage a pellet of 1x107 
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parasites were collected and used for genomic DNA extraction and PCR amplification of the sgRNA with 
a barcoding primer. The sample was sent for Illumina sequencing at the University of California Davis 
Genomic Center on a NEXT Seq (Illumina) with single-end reads using primers (P150 and P151) listed 
in Table S4. 
 
RNA-seq 
3x106 BMDMs were seeded overnight in 6-well plates prior to stimulations. For the stimulated samples, 
IFNγ (100 ng/mL) and/or TNFα (100 ng/mL) were added to each well for 4 or 24 h before harvesting the 
cells for total RNA extractions. The RNA-seq libraries were prepared, sequenced, and processed as 
previously described (96). Briefly, mRNA was purified by polyA-tail enrichment (Dynabeads mRNA 
Purification Kit, Thermo Fisher), fragmented into 200–400 base-pairs, and reverse transcribed into cDNA 
before adding Illumina sequencing adapters to each end. Libraries were barcoded, multiplexed into 4 
samples per sequencing lane in the Illumina HiSeq 2000, and sequenced from both ends resulting in 50 
bp reads after discarding the barcodes. The RNA-sequencing reads were mapped to the mouse genome 
(mm10) using Bowtie (2.0.2) (97) and Tophat (v2.0.4) (98) and transcript abundance estimated in 
cufflinks (99). 
 
Bioinformatic analysis of the loss-of-function screens and RNA-seq  
sgRNA selection and screen analysis were performed using custom software as described in (Sidik et 
al., 2016, 2018) that will be provided upon request. Statistical analyses were performed in R (www.R-
project.org) and Excel (Microsoft Office). Illumina sequencing reads were matched against the sequences 
of the sgRNA library. The number of exact matches was counted and considered as raw read numbers. 
The abundance of each sgRNA was normalized to the total number of reads. To do the log2 transfer, 
sgRNAs that had zero reads were assigned a pseudo-count corresponding to 0.9, which is 90% of the 
lowest sgRNA read in the sample. Only sgRNA whose abundance was above the 5th percentile in the 
input (library) were further considered for the analysis. The ‘‘fitness’’ for each gene was calculated as the 
All rights reserved. No reuse allowed without permission. 
was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint (which. http://dx.doi.org/10.1101/867705doi: bioRxiv preprint first posted online Dec. 6, 2019; 
average log2 fold change for the top five scoring sgRNAs, which minimized the effect of stochastic losses. 
The Pearson correlation between each sample from different screens was calculated. To identify the 
genes that underwent negative selection, the raw reads of each sgRNA between two samples was 
compared and the negative selection P-value of each gene was calculated using the MAGeCK algorithm 
(50). Genes were considered fitness-conferring if they met a significance threshold of negative selection 
P < 0.05 in two out of three screens and/or ≥ 2-fold lower fitness (the fitness between groups is ≤ -1.0) in 
two out of three screens.    
Gene set enrichment analysis (51) was used to determine if Toxoplasma genes that determine 
fitness in specific conditions were enriched in the functional annotation. The genes with fitness-conferring 
in specific conditions were analyzed by using an in-house database that contained information on gene 
ontology (GO), protein family domains (Interpro), KEGG enzyme EC numbers, localization to specific 
organelles, amongst others. Pathways that were enriched in at least two screens are indicated in Table 
S3. For enrichment analysis of BMDM pathways stimulated with IFNγ vs. unstimulated or IFNγ vs. TNFα, 
the GSEA program and MsigDB database was used (51, 100, 101). Psi-blast was used to find 
orthologues of proteins under investigation in other species. Alignments of GRA45 with its orthologs were 
made using PRALINE (102), and the results (Figure S4A) were used as input for HHpred (103) to predict 
similarity to secondary structures of other proteins. In addition, the SWISS-MODEL server was used for 
the homology modeling of protein structures (104). 
 
Plaque assay in MEFs 
Freshly confluent 24 well plates of MEFs were infected with 100 parasites for each well and the plates 
were incubated at 37°C without disturbing for 5 days. The area of each individual plaque was captured 
and analyzed using a Nikon TE2000 inverted microscope equipped with Hamamatsu ORCA-ER digital 
camera, and NIS Elements Imaging Software respectively. For each independent experiment, at least 40 
plaques from technical duplicate wells were imaged. 
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Luciferase assay 
Luciferase assays were performed to determine the fitness of knockout strains in IFNγ-activated 
macrophages. In murine and rat macrophages, BMDMs in 96-well plates (1x105 cells/well) were 
stimulated with IFNγ (1 ng/mL or 5 ng/mL) for 24 h followed by infection with wild-type luciferase-
expressing parasites or knockout parasites at 2 different MOIs (MOI = 0.5 and 1). For human 
macrophages, differentiated THP-1 cells in 96-well plates (1x105 cells/well) were stimulated with human 
IFNγ (50 U/mL or 500 U/mL) for 24 h followed by parasite infection. A plaque assay was set up in HFFs 
at the same time to determine the parasite viability of each parasite strain. After 24 h infection, the cells 
were lysed and luciferase activity was measured as previously described (105). Raw luciferase reads 
(RLU) of unstimulated infected cells was considered as 100 percent and relative parasite growth in IFNγ-
activated macrophages was calculated. To make comparisons between wild-type and knockout parasites, 
“real” MOI was matched to 0.25 from the plaque assay results.  
 
Growth competition 
The BMDMs were left unstimulated or stimulated with IFNγ (1 ng/mL) for 24 h followed by infection with 
a 1:1 mixed ratio of GFP-expressing wild-type parasites and GFP-negative knockout parasites (Δgra22 
or Δrom1). The mixed parasites were allowed to grow in the BMDMs for three lytic cycles. Plaque assays 
of the mixed parasites were performed before putting into the BMDMs and after the 3rd passage in the 
BMDMs, and the number of GFP positive vs. GFP negative plaques were counted to determine the ratio 
of wild type and knockout parasites in naïve BMDMs and IFNγ-activated BMDMs. 
 
Immunofluorescent assay 
To check the localization of GRA45 in extracellular parasites, RHΔku80Δhxgprt::GRA45-3xHA 
tachyzoites released from syringe-lysed HFFs were loaded onto coverslips and fixed with 4% 
Paraformaldehyde (PFA) for 20 minutes followed by permeabilization/blocking with PBS with 3% (w/v) 
BSA, 5% (v/v) goat serum and 0.1% Triton X-100. Co-localization of GRA45 was detected by anti-HA 
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antibodies along with antibodies against ROP2/3/4, GRA1, GRA2, GRA5, GRA7 or SAG1. To determine 
the localization of intracellular GRA45, HFFs grown on glass coverslips were infected with 
RHΔku80Δhxgprt::GRA45-3xHA parasites for 24 h, fixed with 4% PFA for 20 minutes, 
permeabilized/blocked with PBS with 3% (w/v) BSA, 5% (v/v) goat serum and 0.1% Triton X-100, followed 
by incubated with antibodies against the HA epitope tag together with antibodies against ROP2/3/4, 
GRA1, GRA2, GRA5, GRA7 or SAG1 at 4°C overnight. To check the PVM localization of GRA23 or 
export of GRA16 and GRA24, HFFs grown on glass coverslips were infected with wild-type, Δmyr1, 
Δgra45 or Δgra45+GRA45HA strains in the RHΔhxgprt::cLuc background transiently expressing GRA23-
HA-FLAG, GRA16-HA-FLAG or GRA24-HA-FLAG for 20-24 h followed by fixation, permeabilization and 
blocking as described above. The coverslips were incubated with anti-SAG1 antibodies and anti-HA 
antibodies at 4°C overnight. Alexa Fluor 488/594 secondary antibodies and DAPI were used as 
previously described (79). The coverslips were mounted with Vecta-Shield mounting oil and the 
microscopy was performed with NIS-Elements software (Nikon) and a digital camera (CoolSNAP EZ; 
Roper Scientific) connected to an inverted fluorescence microscope (Eclipse Ti-S; Nikon) and either 
phase contrast or DIC imaging. 
 
Cell fractionation 
Purified extracellular parasites were washed with PBS and resuspended in cold PBS containing 1x 
protease and phosphatase inhibitors (Thermo Fisher). Parasites were lysed by six to eight freeze/thaw 
(F/T) cycles using a dry ice-ethanol bath (-70°C) and a 37°C bath. 1/3 of the F/T lysate was kept in PBS, 
1/3 in 1% NP-40, and 1/3 in 1% Triton X-100 for 30 minutes at 4°C under rotation. The PBS, NP-40, and 
Triton X-100 treated lysates were separated by high-speed spin 30 minutes at 20,000 × g. The PBS 
supernatant was precipitated with TCA (Trichloroacetic Acid), NP-40, and Triton X-100 supernatants 
were acetone precipitated. For intracellular parasites, tachyzoites were allowed to infect HFF monolayers 
for 24 h. The infected monolayers were washed three times with PBS, mechanically lysed in PBS 
containing 1x protease and phosphatase inhibitors (Thermo Fisher) using 27-gauge needles, and 
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parasites were pelleted by low-speed spin for 10 minutes at 2500 × g (LSP). The low-speed supernatant 
(LSS) containing PV membranes and soluble material was further fractionated at 100,000 x g at 4°C for 
one hour to yield the high-speed pellet (HSP) and high-speed supernatant (HSS). Half of the HSP was 
treated with 1% Triton X-100 for 30 minutes at 4°C under rotation and fractionated again at 20,000 x g at 
4°C for one hour to obtain the Triton X-100 treated high-speed pellet and high-speed supernatant. 
 
Immunoblotting  
Samples from the extracellular and intracellular fractionations were boiled for 10 minutes in sample buffer, 
separated by SDS-PAGE, and transferred to polyvinylidene difluoride (PVDF) membranes. Membranes 
were blocked in 5% milk in TBS supplemented with 1% Tween-20 (TBS-T) for 30 minutes at room 
temperature and then incubated overnight at 4°C with primary antibody in blocking buffer. GRA1, GRA2, 
GRA5 blots were subsequently incubated with an anti-mouse secondary horseradish peroxidase (HRP)-
conjugated antibody (Roche). The GRA7 blot was incubated with a secondary antibody (HRP)-
conjugated anti-rabbit antibody (Roche). The HRP was detected using an enhanced chemiluminescence 
(ECL) kit (Pierce). Between each blot, the membranes were stripped by incubation in stripping buffer 
(Thermo Fisher) for 20 minutes and subsequently washed three times for five minutes with TBS-T. 
 
In vivo infection 
Toxoplasma tachyzoites were harvested from cell culture and released by passage through a 27-gauge 
needle, followed by a 30-gauge needle. C57BL/6J mice were intraperitoneally (i.p.) infected with 100 
tachyzoites of each strain and parasite viability of the inocula was determined in a plaque assay after 
infection. The mice were monitored for 30 days p.i., and the number of dead mice per group was observed 
every individual day. 
 
Statistical Tests  
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All statistical analyses were performed using Prism (GraphPad) version 8.0. The luciferase assays are 
presented as paired scatterplots for independent experiment whereas all the other data are presented as 
average ± standard deviation (SD), and the exact n values are mentioned in the figure legends. For all 
the calculations p < 0.05 are considered as significant and represented with an Asterix. To compare 
parasite growth of the knockouts vs. wild-type parasites in IFNγ-activated cells, paired t test was used. 
For more than three groups with one variable in the other data, One-way ANOVA with Tukey’s multiple 
comparisons test was used. For one variable test with two groups, the two-way ANOVA with Tukey’s 
multiple comparisons test was used. Survival experiments were analyzed using the log rank (Mantel-Cox) 
test.  
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TABLE AND LEGENDS 
Table 1. Toxoplasma genes that determine fitness in naïve or IFNγ-activated macrophages  
Genes with a fitness defect in naïve macrophages 
Gene ID Product Description Naïve BMDM 
vs. HFF-P6/P8 
Fitness 
Negative 
Enriched 
P-Value 
HFF-P3/P4 
Fitness 
Naïve BMDM 
Fitness 
IFNγ BMDM vs. 
Naïve BMDM 
Fitness / P-Value 
TGGT1_249580 TgApiAT6-3 -4.2 7E-07 1.6 -2.8 -0.2 / 0.6 
TGGT1_253780 Putative GTP cyclohydrolase I -3.7 0.06 1.3 -5.0 -0.6 / 0.5 
TGGT1_247360 PAP2 superfamily protein -3.2 0.07 0.5 -4.2 -1.2 / 0.2 
TGGT1_305800 6-pyruvoyl tetrahydrobiopterin 
synthase 
-2.5 0.01 -0.3 -5.7 0.4 / 0.8 
TGGT1_250880 Kinase, pfkB family protein 
(Adenosine Kinase) 
-1.8 0.07 0.8 -2.3 1.2 / 0.7 
TGGT1_290860 TgApiAT6-2 -1.5 0.02 0.6 -1.7 0.5 / 0.8 
TGGT1_243970 Lipovitellin-like (Swiss-
Model/HHpred) 
-1.5 0.1 -1.4 -4.1 1.0 / 0.8 
TGGT1_224840 3'5'-cyclic nucleotide 
phosphodiesterase domain-
containing protein 
-1.3 0.04 -0.9 -2.5 0.3 / 0.6 
TGGT1_310000 G-protein-coupled receptor-like 
(Swiss-Model/HHpred) 
-1.1 0.09 -0.1 -3.1 -7.9E-03 / 0.4 
Genes with a fitness defect in IFNγ-activated macrophages 
Gene ID Product Description IFNγ BMDM 
vs. Naïve 
BMDM Fitness 
Negative 
Enriched 
P-Value 
HFF-P3/P4 
Fitness 
Naïve BMDM 
vs. HFF-P6/P8 
Fitness 
IFNγ BMDM vs. 
TNFα BMDM 
Fitness (S3) / P-
Value 
TGGT1_269620 DNA repair protein-like (Swiss-
model) 
-4.0 0.005 1.0 1.5 -3.0 / 0.005 
TGGT1_209500 DNA repair protein-like (HHpred) -3.6 2E-05 2.1 0.4 -2.3 / 5E-05 
TGGT1_295340 UV excision repair protein Rad23 
protein 
-3.5 0.002 1.1 1.4 -3.5 / 6E-05 
TGGT1_316250 GRA45 -3.3 9E-04 1.7 1.0 -2.2 / 0.03 
TGGT1_232670 Cytohesin-3-like; GEF of Arf6 
(Swiss-Model) 
-3.3 0.05 1.3 0.3 -1.9 / 0.1 
TGGT1_321530 Cathepsin L (CPL) -3.3 0.009 1.4 1.7 -1.6 / 0.005 
TGGT1_263560 Putative GRA#, ER-resident 
protein (ToxoDB) 
-3.0 5E-04 1.3 1.5 -1.8 / 2E-04 
TGGT1_205350 Putative integral membrane 
protein, GNS1/SUR4 family 
protein 
-3.0 0.04 1.2 0.7 -3.7 / 5E-04 
TGGT1_208370 GRA46 -3.0 0.01 1.2 0.5 -0.9 / 0.007 
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TGGT1_231210 Sarcalumenin/eps15 family 
protein (Dynamin like protein; 
Swiss-Model/HHpred) 
-3.0 0.03 0.3 1.0 -1.9 / 0.005 
TGGT1_228300 CCDC25 protein -2.9 0.05 0.8 0.3 -2.3/ 0.003 
TGGT1_215220 GRA22 -2.9 0.03 1.0 1.1 -0.6 / 0.4 
TGGT1_314500 SUB2 -2.8 0.04 1.3 0.8 -1.7 / 4E-04 
TGGT1_221170 CAAX metallo endopeptidase -2.7 0.03 -0.2 1.8 -1.2 / 0.05 
TGGT1_200290 ROM1 -2.4 0.01 1.2 0.2 -1.0 / 0.002 
TGGT1_240980 Cytoplasmic dynein-like (Swiss-
Model/HHpred) 
-2.4 0.004 1.3 0.3 -2.0 / 0.02 
TGGT1_269950* Putative GRA#  -2.1 0.2 -0.7 -2.7 -0.4 / 0.04 
 
Upper panel: 9 top hits, selected from 130 naïve BMDM fitness-conferring genes, with a negative 
selection of sgRNAs (average P < 0.1) and ≥ 2-fold lower fitness (fitness score ≤ -1) in naïve BMDMs 
vs. HFF-P6/P8. Genes without expression in murine macrophages (90) and with a Naïve BMDM fitness 
≥ -1 in two out of three screens were removed.  
Lower panel: 16 top hits, selected from 466 IFNγ fitness-conferring genes, with a significant negative 
selection of sgRNAs (average P < 0.05), a ≥ 4-fold lower fitness (fitness score ≤ -2) in IFNγ-activated 
vs. naïve BMDMs, and at least 4 sgRNAs present in the 3rd passage of naïve BMDMs. Genes without 
expression in murine macrophages (90) and with an average IFNγ BMDM fitness ≤ 0 were removed.  
The genes are ranked according to the Naïve BMDM vs. HFF-P6/P8 fitness (n = 3, upper panel) or the 
mean IFNγ BMDM vs. Naïve BMDM fitness (n = 3, lower panel). See Table S2 for the complete list.  
*, TGGT1_269950 was confirmed as an IFNγ fitness-conferring gene with individual knockout (Figure 
2), although it does not fit the above criteria. 
#,  The putative GRAs are predicted based on a published proteomic study (54). 
 
SUPPLEMENTAL INFORMATION  
Supplemental Table S1  
Sheet 1 “BMDM_AJ_B6_IFNGvsTNFvsIFNTNF_FP”: RNAseq data of A/J and C57BL/6J BMDMs 
stimulated with IFNγ and/or TNFα for 4 or 24 h or left unstimulated. RPKM values are indicated. Genes 
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involved in the cholesterol synthesis pathway are indicated as are pathways mediating cholesterol 
biosynthesis.  
Sheet 2 “GSEA_IFN4-24hvsTNF4-24h”: Gene Set Enrichment Analysis (GSEA) was performed on the 
BMDMs stimulated with IFNγ vs. TNFα. For this analysis the A/J, C57BL/6J at 4 and 24 h were treated 
as four replicates to identify pathways regulated regardless of mouse strain or duration of stimulation. 
All data in sheet 1 was used and genes were ranked based on the differential expression between the 
two conditions identified using the Signal2Noise option in the stand-alone version of GSEA. KEGG and 
Hallmark gene sets from the MSigDB database were used to identify positively or negatively enriched 
gene sets. A P-value cut-off of 0.05 was used but FDRs are also displayed. 1,000 gene set 
permutations were used to determine P-values and FDRs. 
Sheet 3 “GSEA IFN4-24 vs NS4-24”: As in “Sheet 2” but comparing BMDMs stimulated with IFNγ vs. 
non-stimulated (NS) BMDMs. 
Sheet 4 “GSEA TNF4-24vs NS4-24”: As in “Sheet 2” but comparing BMDMs stimulated with TNFα vs. 
non-stimulated (NS) BMDMs. 
 
Supplemental Table S2 
This table contains the raw sgRNA reads for each experiment, the fitness scores, and a list with all 
Toxoplasma genes and all associated screen information. 
 
Supplemental Table S3 
Gene Set Enrichment Analysis (GSEA) using the pre-ranked option was performed on Toxoplasma 
genes, with at least 3 sgRNAs in either condition, ranked according to their Naive BMDM vs. HFF-P6/8 
P-values or according to their IFNγ BMDM vs. Naive BMDM P-values (see Supplementary Table S2). 
Only gene sets containing at least five genes were analyzed and only those gene sets enriched in at 
least 2 out of the 3 screens with in at least one screen a P-value <0.05 are listed. For enrichments 
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mentioned in the main text but not listed in this table the “results analysis” option in ToxoDB.org on the 
top hits was used. 
 
Supplemental Table S4 
Primers and oligos used in this study. 
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Figure 1:  
 
Figure 1. Toxoplasma gondii genome-wide loss-of-function screen in naïve or IFNγ-stimulated 
murine bone marrow-derived macrophages 
(A) Screening workflow. At least 5x108 Cas9-expressing RH parasites were transfected with linearized 
plasmids containing 10 sgRNAs against every Toxoplasma gene. Transfected parasites were passaged in 
HFFs under pyrimethamine selection to remove non-transfected parasites and parasites that integrated 
plasmids with sgRNAs targeting parasite genes important for fitness in HFFs. Subsequently, the pool of 
mutant parasites was either continuously passaged in HFFs or passaged for three rounds in murine 
BMDMs that were left unstimulated or pre-stimulated with IFNγ. The sgRNA abundance at different 
passages, determined by illumina sequencing, was used for calculating fitness scores and identify genes 
that confer fitness in naïve or IFNγ-activated BMDM. 
(B) Timeline for the generation of mutant populations and subsequent selection in the presence or absence 
of murine IFNγ or TNFα. Times at which parasites were passaged (P) are indicated. 
(C) Potential bottlenecks were assessed by determining the number of sgRNAs targeting control genes. 
The genes are ranked according to the number of sgRNAs in HFFs (P3 or P4) with the genes on top having 
the lowest sgRNA number. The scale bar indicates the sgRNA number of genes colored with graded red. 
Genes with 4 or more sgRNAs are colored red; otherwise, the gene is colored in a graded red scale based 
on how many sgRNAs were present in each sample.  
(D) Correlation between mean Naïve BMDM fitness and mean HFF-P6/P8 fitness. Orange dots indicate the 
top 9 candidate genes that confer fitness in naïve BMDMs compared to HFFs (Table 1).  
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(E) Correlation between mean IFNγ-activated BMDM fitness and mean Naïve BMDM fitness of all the 
genes. Red dots indicate the top 16 IFNγ fitness-conferring candidate genes in murine BMDMs and orange 
dots the top 9 genes conferring fitness in naïve BMDMs compared to HFFs (Table 1).   
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Figure S1:  
 
Figure S1. IFNγ restricts parasite growth in murine BMDMs, related to Figure 1  
(A) Murine BMDMs pre-stimulated with IFNγ (1 or 100 ng/mL) or left unstimulated for 24 h were infected 
with luciferase-expressing type 1 (RH) parasites for 24 h and parasite growth was measured by luciferase 
assay. Parasite growth in IFNγ-activated BMDMs is expressed relative to growth in naïve BMDMs. Data are 
displayed as average ± SD for 3 independent experiments. Asterisk (*) indicates a significant difference 
analyzed with one-way ANOVA with Tukey’s multiple comparisons test: p = 0.04 for IFNγ (100 ng/mL) 
stimulated BMDMs vs. naïve BMDMs.  
(B) Murine BMDMs pre-stimulated with IFNγ (100 ng/mL) and/or TNFα (10 ng/mL) for 24 h or left 
unstimulated were infected with luciferase-expressing RH parasites for another 24 h and parasite growth 
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was measured by luciferase assay. Parasite growth in stimulated BMDMs is expressed relative to growth in 
naïve BMDMs. Data are displayed as average ± SD for 4 independent experiments. Asterisk (*) indicates a 
significant difference analyzed with one-way ANOVA with Tukey’s multiple comparisons test: p < 0.0001 for 
TNFα + IFNγ stimulated BMDMs vs. both naïve BMDMs and TNFα stimulated BMDMs. 
(C) IFNγ-regulated genes in C57BL/6J and A/J murine BMDMs pre-stimulated with 100 ng/mL IFNγ were 
defined by a ≥ 4-fold change (IFNγ-activated BMDMs vs. naïve BMDMs) in gene expression values 
(FKPM). Data are displayed as a heat map of log2-fold change of the 251 genes with either ≥ 4-fold 
upregulated (197 genes) or ≥ 4-fold downregulated (54 genes) in IFNγ-activated BMDMs (n = 2). The 
complete set of genes is listed in Table S1.  
(D) Differentially regulated pathways between unstimulated vs. IFNγ- vs. TNFα-stimulated BMDMs were 
identified using GSEA analysis and the MSigDB database. The 4 and 24 h time points from A/J and 
C57BL6/J murine BMDMs were treated as replicates as the goal was to identify pathways that are similarly 
regulated between these samples. As an example, the downregulation of the cholesterol homeostasis 
pathway in IFNγ-activated vs. Naive BMDMs and IFNγ-activated vs. TNFα-activated BMDMs are shown. 
(E) An example of specific genes involved in the cholesterol homeostasis pathway (from D) regulated in 
IFNγ-stimulated murine BMDMs are presented as heat plots. Exact RPKM values of genes involved in 
cholesterol metabolism is presented in Table S1.   
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Figure 2:  
 
Figure 2. Validation of candidate genes that determine parasite fitness in IFNγ-stimulated murine 
BMDMs. 
(A to F) Murine BMDMs pre-stimulated with IFNγ (1 or 5 ng/mL) or left unstimulated for 24 h were infected 
with luciferase-expressing wild-type (WT) parasites or with parasites in which (A) TGGT1_269620, (B) 
GRA45, (C) TGGT1_232670, (D) TGGT1_263560, (E) GRA22 or (F) TGGT1_269950 was knocked-out 
(MOI of 0.25). 24 h p.i. parasite growth for each strain was measured by luciferase assay. Parasite growth 
in IFNγ-activated BMDMs is expressed relative to growth in naïve BMDMs. Data are displayed as paired 
plots of at least 3 independent experiments. Asterisk (*) indicates a significant difference between WT and 
knockout analyzed with two-tailed paired t test: (A) n = 6, p = 0.02 for 1 ng/mL IFNγ, p = 0.007 for 5 ng/mL 
IFNγ; (B) n = 3, p = 0.02 for 1 ng/mL IFNγ; (C) n = 5, p = 0.04 for 5 ng/mL IFNγ; (D) n = 5, p = 0.006 for 1 
ng/mL IFNγ, p = 0.01 for 5 ng/mL IFNγ; (E) n = 4, p = 0.006 for 1 ng/mL IFNγ, p = 0.02 for 5 ng/mL IFNγ; 
(F) n = 5, p = 0.03 for 1 ng/mL IFNγ.  
(G and H) Growth competition assay between GFP-positive WT parasites and GFP-negative (G) Δgra22 or 
(H) Δrom1 parasites was performed in murine BMDMs pre-stimulated with 1 ng/mL IFNγ or left 
unstimulated for 3 passages. The percentage of Δgra22 or Δrom1 was determined at the start of the 
competition and after 3 passages by plaque assay measuring the GFP-negative plaques vs. total plaques. 
Data are displayed as paired plots for Δgra22 (n = 3) and for Δrom1 (n = 2). Asterisk (*) indicates a 
significant difference between the ratio of WT vs. knockout before and after competition analyzed with two-
tailed paired t test: (G) p = 0.04 for 1 ng/mL IFNγ-activated BMDMs; (H) p = 0.04 for 1 ng/mL IFNγ-
activated BMDMs.  
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Figure S2:
 
Figure S2. Generation and confirmation of knockout and complemented parasites, related to Figure 
2 
(A) Schematic diagram depicting the genomic loci of the genes of interest (GOI) (top) and the 
CRISPR/Cas9-targeting site (red box). Linearized pTKO plasmid containing GFP-coding sequence 
and HXGPRT selection cassette (middle) was used as a repair template to disrupt the GOI (bottom) 
after mycophenolic acid and xanthine selection. P1 and P2 refer to the primers used for confirming 
locus disruption. P1 + P3 or P2 + P3 are used to check insertion of the repair template into the GOI locus.  
(B) GRA45 complementation was performed by homologous recombination of GRA45HA-expressing 
cassette (middle) into UPRT locus (top). The coding sequence of UPRT was replaced with GRA45HA 
(bottom) after FUDR selection. 
(C) Schematic strategy used to delete the entire coding region of GRA45 (top) by inserting DHFR* in 
RHΔku80::MYR1-3xHA strain. Transfection of the sgRNAs targeting GRA45 locus (red box) together 
with the DHFR*-expressing amplicon flanking with 60bp of 5-’UTR and 3’-UTR of GRA45 (middle) after 
pyrimethamine selection was used to generate GRA45 deletions. 
(D) GRA45 knockout in RH-Luc+/Δhxgprt parasites and complementation of the gene in the UPRT locus.  
(E) TGGT1_263560 knockout in RH-Luc+/Δhxgprt parasites. 
(F) TGGT1_269620 (top), TGGT1_232670 (middle) and MYR1 (bottom) knockout in RH-Luc+/Δhxgprt 
parasites. 
(F and G) Individual knockout of GRA22 (F) or ROM1 (G) in RH-Cas9Δhxgprt background. 
(I) GRA45 knockout in RHΔku80::MYR1-3xHA parasites.  
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Figure S3: 
 
Figure S3. Parasite growth in naïve murine BMDMs and MEFs of individual knockouts of genes 
identified from loss-of-function screen in IFNγ-stimulated BMDM, related to Figure 2 (A to F) Raw 
luciferase reads (RLU) of WT, ΔTGGT1_269620 (A, n = 6), ΔTGGT1_232670 (B, n = 5), ΔTGGT1_263560  
(C, n = 4), Δgra22 (D, n = 3), ΔTGGT1_269950 (E, n = 4) or Δgra45 (n = 6) and Δgra45+GRA45HA (F, n = 
6 for Δgra45, n = 3 for Δgra45+GRA45HA) parasites in naïve murine BMDMs were normalized to 100% 
viability based on their viability measured by plaque assays. Data are displayed as averages ± SD for at 
least 3 independent experiments. Asterisk (*) indicates a significant difference between WT and knockout 
analyzed with two-tailed paired t test: p = 0.01 for (D). 
(G) Confluent MEFs were infected with indicated parasites for 5 days. An area of at least 40 plaques per 
experiment was measured. Data are displayed as averages ± SD for 3 independent experiments with 
plaque area relative to the WT plaque area (n = 3). Asterisk (*) indicates a significant difference analyzed 
with one-way ANOVA with Tukey’s multiple comparisons test: p = 0.02 for WT vs. ΔTGGT1_263560. 
(H) Representative images of plaque size and morphology of WT, Δgra22, and ΔTGGT1_263560 parasites 
in MEFs (scale bar = 200 μm).  
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Figure 3:  
 
Figure 3. Δgra45 parasites, but not Δgra22 parasites, have enhanced susceptibility to IFNγ-
mediated growth inhibition in rat BMDMs and human THP-1 macrophages. 
(A) Brown Norway rat BMDMs pre-stimulated with or without IFNγ (1 ng/mL or 5 ng/mL) were infected with 
luciferase-expressing WT, Δgra22 or Δgra45 parasites (MOI of 0.25) for 24 h. Parasite growth for each 
strain was measured by luciferase assay and the growth in IFNγ-activated BMDMs is expressed relative to 
growth in naïve BMDMs. Data are displayed as paired plots for 3 independent experiments. Asterisk (*) 
indicates a significant difference analyzed by one-way ANOVA with Tukey’s multiple comparisons test: p = 
0.007 for WT vs. Δgra45 in BMDMs stimulated with 1 ng/mL IFNγ, p = 0.002 for WT vs. Δgra45 in BMDMs 
stimulated with 5 ng/mL IFNγ. 
(B) PMA-differentiated THP-1 macrophages pre-stimulated with or without IFNγ (50 U/mL or 500 U/mL) 
were infected with luciferase-expressing WT, Δgra22 or Δgra45 parasites (MOI of 0.25) for 24 h. Parasite 
growth for each strain was measured by luciferase assay and the growth in IFNγ-activated BMDMs is 
expressed relative to growth in naïve BMDMs. Data are displayed as paired plots with n = 2 for Δgra22 and 
n = 3 for WT and Δgra45. Due to different n between Δgra22 and Δgra45, the significant difference was 
analyzed with two-tailed paired t test. Asterisk (*) indicates p = 0.02 for WT vs. Δgra45 in THP-1 
macrophages stimulated with 50 U/mL IFNγ. 
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Figure 4:  
 
Figure 4. In Δgra45 parasites other GRAs are aggregated and mislocalized after secretion into the 
vacuole. 
(A) Extracellular parasites of WT, Δgra45 or Δgra45 + GRA45HA strains were disrupted by freeze/thaw 
cycles followed by incubating with PBS, 1% NP-40 or 1% Triton X-100 and fractionating by high-speed 
centrifugation to separate the pellet (P) and supernatant (S). GRA2 and GRA7 were detected with indicated 
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antibodies. SAG1 was used as the parasite loading control. The image is representative of results from two 
independent experiments. 
(B) HFFs were infected with WT, Δgra45, or Δgra45 + GRA45HA parasites for 24 h followed by mechanical 
disruption of host cells and separating intact parasites (LSP) and membrane fraction (LSS) via low-speed 
centrifugation. The PVM fraction was harvested and incubated with PBS, 1% NP-40 or 1% Triton X-100 
and fractionated by high-speed centrifugation to separate the pellet (HSP) and supernatant (HSS). Western 
blots were developed with antibodies against GRA1, GRA2, GRA5, and GRA7. Red stars indicate the 
samples containing a phosphorylated form of GRA7. 
(C) HFFs were infected with WT, Δgra45 or Δmyr1 parasites that transiently expressed GRA23-HA followed 
by fixing and staining with antibodies against SAG1 (green) and the HA epitope (red). The images are 
representative of results from two independent experiments and were taken at identical exposure times for 
each channel (scale bar = 5 μm).  
(D) Localization of GRA23 in at least 50 vacuoles containing 4 or more parasites was observed and the 
percentage of PV lumen localized GRA23 was quantified. Data are displayed as averages ± SD with n = 2 
for Δmyr1 and n = 3 for WT and Δgra45. Due to different n between Δmyr1 and Δgra45, the significant 
difference was analyzed with two-tailed paired t test. Asterisk (*) indicates a p = 0.02 for WT vs. Δgra45. 
(E) Extracellular WT parasites expressing endogenously 3xHA-tagged MYR1 or Δgra45 parasites in this 
background were disrupted by freeze/thaw cycles followed by incubating with PBS, 1% NP-40 or 1% Triton 
X-100 and fractionated by high-speed centrifugation to separate the pellet (P) and supernatant (S). The C-
terminal polypeptide of MYR1 was detected with anti-HA antibodies. SAG1 was used as the parasite 
loading control.  
(F) WT, Δmyr1, Δgra45, or Δgra45 + GRA45HA parasites were transiently transformed with GRA16-HA-
FLAG expressing plasmid and immediately used to infect HFFs and fixed at 24 h p.i. and subjected to the 
immunofluorescent assay with indicated antibodies. The image is representative of results from three 
independent experiments and was taken at identical exposure times for each channel (scale bar = 10 μm).  
(G) GRA16 nuclear intensity was quantified in host cells containing a single parasitophorous vacuole with 4 
or more parasites for at least 30 host cells. Data are displayed as averages ± SD relative to GRA16 nuclear 
intensity of WT-infected cells for 3 independent experiments. Asterisk (*) indicates a significant difference 
analyzed with one-way ANOVA with Tukey’s multiple comparisons test: p = 0.008 for WT vs. Δmyr1, p = 
0.009 for WT vs. Δgra45, p = 0.01 for Δgra45 vs. Δgra45 + GRA45HA. 
(H) WT, Δmyr1, Δgra45, or Δgra45 + GRA45HA parasites were transiently transformed with a GRA24-HA-
FLAG expressing plasmid and immediately used to infect HFFs and fixed at 24 h p.i. and subjected to the 
immunofluorescent assay with indicated antibodies. The image is representative of results from three 
independent experiments and was taken at identical exposure times for each channel (scale bar = 10 μm). 
(I) GRA24 nuclear intensity was quantified in host cells containing a single parasitophorous vacuole with 4 
or more parasites for at least 30 host cells. Data are displayed as averages ±SD relative to GRA24 nuclear 
intensity of WT-infected cells for 3 independent experiments. Asterisk (*) indicates a significant difference 
analyzed with one-way ANOVA with Tukey’s multiple comparisons test: p = 0.01 for WT vs. Δmyr1, p = 
0.01 for WT vs. Δgra45, p = 0.005 for Δgra45 vs. Δgra45 + GRA45HA.  
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Figure S4:  
 
Figure S4. The subcellular localization and predicted structure of GRA45. Related to Figure 4  
(A) Alignment of GRA45 from Toxoplasma gondii type 1 (TGGT1_316250), 2 (TGME49_316250) and 3 
(TGVEG_316250); Toxoplasma gondii TGRUB_295390; Hammondia hammondi HHA_316250; Neospora 
caninum NCLIV_058760; Cystoisospora suis CSUI_003845; Sarcocystis neurona SN3_01000185; Eimeria 
acervulina EAH_00055290; Eimeria necatrix ENH_00009810; Cyclospora cayetanensis cyc_02015. Blue 
box indicates TEXEL motif. Red boxes and black boxes indicate predicted small heat shock protein (HSP) 
domain and predicted transthyretin-like fold, respectively.  
(B) Extracellular parasites (left panel) or intracellular parasites (right panel) expressing endogenously HA-
tagged GRA45 were fixed, permeabilized, and subjected to immunofluorescent assays with the indicated 
antibodies. (scale bar = 2 μm for extracellular and 5 μm for intracellular parasites).  
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Figure 5:  
 
Figure 5. Compared to Δmyr1 parasites, Δgra45 parasites are more susceptible to IFNγ and less 
virulent in mice. 
(A) Toxoplasma genes that have at least 3 sgRNAs present after the 3rd passage in naïve BMDM in the 
three screens are rank-ordered according to their IFNγ vs. naïve BMDM fitness scores. Data are displayed 
as average fitness scores (black plots) ±SD (gray lines).  
(B) IFNγ vs. naïve BMDM fitness scores of GRA45, MYR1, MYR2, and MYR3. Data are displayed as 
averages ± SD for 3 independent screens. Asterisk (*) indicates a significant difference analyzed with one-
way ANOVA with Tukey’s multiple comparisons test: p = 0.005 for GRA45 vs. MYR1, p = 0.003 for GRA45 
vs. MYR2, p = 0.009 for GRA45 vs. MYR3. 
(C) Murine BMDMs pre-stimulated with or without IFNγ (1 ng/mL, 5 ng/mL, 10 ng/mL or 50 ng/mL) were 
infected with luciferase-expressing WT, Δmyr1, Δgra45, or Δgra45 + GRA45HA parasites (MOI of 0.25) for 
24 h. Parasite growth for each strain was measured by luciferase assay and the growth in IFNγ-activated 
BMDMs is expressed relative to growth in naïve BMDMs. Data are displayed as connecting lines with an 
average of four independent experiments ± SD. Asterisk (*) indicates a significant difference analyzed with 
two-way ANOVA with Tukey’s multiple comparisons test: p < 0.0001 for WT vs. Δgra45, p < 0.0001 for 
Δgra45 vs. Δgra45 + GRA45HA, p = 0.01 for Δmyr1 vs. Δgra45. 
(D) CD-1 mice were i.p. infected with 100 tachyzoites of WT, Δmyr1, Δgra45 or Δgra45 + GRA45HA 
parasites and survival of mice was monitored for 30 days. Data are displayed as Kaplan-Meier survival 
curves. Asterisk (*) indicates a significant difference analyzed with Log-rank (Mantel-Cox) test: p < 0.0001 
for WT vs. Δgra45, p = 0.006 for Δgra45 vs. Δgra45 + GRA45HA, p = 0.007 for Δmyr1 vs. Δgra45. 
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